Metraipolis › archive › dc_fbb1dd58283c
Superior anti-DLBCL efficacy of novel organic arsenical Z2-A-Z2 through ROS-mediated apoptosis and critical NF-κB/IκBα signaling pathway inhibition — Europe PMC PMID:42152103
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42152103
- DOI
- 10.1186/s13046-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T04:49:32.943Z
- SHA-256 of the archived text
4ad910654e648d945271803e3ea95bf3a9104249085fefef575eedfc79f73025- Stable URL of this page
https://metraipolis.com/documento/dc_fbb1dd58283c
How to cite
Superior anti-DLBCL efficacy of novel organic arsenical Z2-A-Z2 through ROS-mediated apoptosis and critical NF-κB/IκBα signaling pathway inhibition — Europe PMC PMID:42152103 — Europe PMC (en), https://europepmc.org/article/MED/42152103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbb1dd58283c (Metraipolis archive dc_fbb1dd58283c, sha256 4ad910654e648d945271803e3ea95bf3a9104249085fefef575eedfc79f73025)
BibTeX
@misc{dcfbb1dd58283c,
title = {Superior anti-DLBCL efficacy of novel organic arsenical Z2-A-Z2 through ROS-mediated apoptosis and critical NF-κB/IκBα signaling pathway inhibition — Europe PMC PMID:42152103},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42152103},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbb1dd58283c; sha256 4ad910654e648d945271803e3ea95bf3a9104249085fefef575eedfc79f73025},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152103. Agents can read the archived copy with the MCP tool read_document.